// Daily US stock report
October 13, 2026
Premarket and post-market candidates with catalyst context and Trend Join Long scanner decisions.
04:00-09:30 ET
Premarket Scan
08:48 ET scan: 2 candidates were checked. Neither passed both the daily trend and premarket breakout tests.
| Symbol | Market cap | Premarket price | Gap | Premarket volume | 20-day average volume | Premarket / average | What probably caused it | Why it fit the premarket candidate filter | Why it fit the trend scanner report or failed to fit the trend scanner |
|---|---|---|---|---|---|---|---|---|---|
| FRMI | $2.08B | $3.670 | +13.88% | 4,550,794 | 17,465,466 | 26.06% | Fermi announced a credit-support agreement with AMD for the first 222 MW phase of Project Matador and a partnership framework for potential expansion to 650 MW. Confirmed. | At the candidate scan it had a $2.08B market cap, a $3.701 premarket price, a 13.88% gap, 4,550,794 premarket shares, and premarket volume equal to 26.06% of its 20-day average. | fail_daily. Current price $3.670 > previous daily high $3.390, but previous close $3.250 was not > SMA200 $6.8746. Current price $3.670 was also not > premarket high $4.290. |
| UNH | $339.76B | $396.195 | +5.28% | 420,642 | 5,113,150 | 8.23% | UnitedHealth reported $112.7B in third-quarter revenue, adjusted EPS of $4.69, and raised full-year adjusted EPS guidance to at least $20.50. Confirmed. | At the candidate scan it had a $339.76B market cap, a $398.490 premarket price, a 5.28% gap, 420,642 premarket shares, and premarket volume equal to 8.23% of its 20-day average. | fail_intraday. Current price $396.195 > previous daily high $382.980 and previous close $378.520 > SMA200 $357.7938, but current price $396.195 was not > premarket high $399.497. |
Average volume is the mean regular-session volume over the latest 20 completed trading days. Higher relative volume indicates stronger participation, but it does not prove that a breakout is real or durable.
09:30-20:00 ET
Regular + Post-market Scan
20:47 ET scan: 1 post-market candidate was checked. It did not pass the daily trend test.
| Symbol | Market cap | Post-market price | Gap | Daily + post-market volume | 20-day average volume | Daily + post-market / average | What probably caused it | Why it fit the post-market candidate filter | Why it fit the trend scanner report or failed to fit the trend scanner |
|---|---|---|---|---|---|---|---|---|---|
| LQDA | $2.40B | $38.192 | +42.45% | 4,198,464 Regular: 1,782,017 · Post-market: 2,416,447 |
5,078,983 | 82.66% | Liquidia announced a global settlement resolving all six pending lawsuits with United Therapeutics, preserving uninterrupted YUTREPIA access for PAH while requiring $380.7 million in net payments across 2026 and 2027. Confirmed. | It had a $2.40B market cap, a $38.192 final post-market price, a 42.45% gain from the $26.810 regular close, 2,416,447 post-market shares, and combined volume equal to 82.66% of its 20-day average. | fail_daily. Post-market price $38.192 > regular high $27.400, but regular close $26.810 was not > SMA200 $53.9274. It also did not hold within 2% of the $42.050 post-market high: $38.192 was below the $41.209 threshold. |
Average volume is the mean regular-session volume over the 20 completed trading days before this session. Higher relative volume indicates stronger participation, but it does not prove that a breakout is real or durable.
Research only. This is not investment advice, and no trade is placed by either scanner.